Financhill
Sell
45

KHNGY Quote, Financials, Valuation and Earnings

Last price:
$43.91
Seasonality move :
2.65%
Day range:
$43.44 - $44.38
52-week range:
$36.76 - $49.66
Dividend yield:
4.46%
P/E ratio:
21.68x
P/S ratio:
0.87x
P/B ratio:
9.99x
Volume:
2.4K
Avg. volume:
21.7K
1-year change:
-4.79%
Market cap:
$26.1B
Revenue:
$28.2B
EPS (TTM):
$2.03

Earnings Data

Next earnings date for KHNGY
Mar 03
2026
Most recent earnings per share
$0.42
Beat by $0.42
(Oct 23/2025)
Consensus Estimate
--
(Oct 23/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KHNGY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
10/23/2025 Q3 -- $7.6B $0.42 -- --
07/24/2025 Q2 -- $7.4B $0.50 -- --
04/24/2025 Q1 -- $7B $0.55 -- --
03/04/2025 Q4 -- $7.7B $0.57 -- --
10/23/2024 Q3 -- $7.5B $0.63 -- --
07/23/2024 Q2 -- $6.7B $0.54 -- --
04/23/2024 Q1 -- $6.3B $0.53 -- --
03/01/2024 Q4 -- $6.4B $0.49 -- --
10/25/2023 Q3 -- $6.2B $0.60 -- --
07/25/2023 Q2 -- $6.6B $0.75 -- --
04/25/2023 Q1 -- $7.3B $0.82 -- --
03/01/2023 Q4 -- $9.1B $0.78 -- --
10/25/2022 Q3 -- $10.3B $1.13 -- --
07/25/2022 Q2 -- $10.9B $1.30 -- --
04/26/2022 Q1 -- $11B $1.41 -- --
03/02/2022 Q4 -- $11.9B $1.30 -- --
10/20/2021 Q3 -- $9.3B $1.01 -- --
07/20/2021 Q2 -- $8B $0.80 -- --
04/26/2021 Q1 -- $6.7B $0.58 -- --
03/03/2021 Q4 -- $6.1B $0.39 -- --
10/20/2020 Q3 -- $5.5B $0.48 -- --
07/21/2020 Q2 -- $5.1B $0.29 -- --
03/31/2020 Q1 -- $5.1B $0.24 -- --
12/31/2019 Q4 -- $5.3B $0.34 -- --
09/30/2019 Q3 -- $5.3B $0.36 -- --
06/30/2019 Q2 -- $5.3B $0.34 -- --
03/31/2019 Q1 -- $5.3B $0.30 -- --
12/31/2018 Q4 -- $5.4B $0.32 -- --
09/30/2018 Q3 -- $5.4B $0.32 -- --
06/30/2018 Q2 -- $5.3B $0.35 -- --
03/31/2018 Q1 -- $5.1B $0.32 -- --
12/31/2017 Q4 -- $5.1B $0.34 -- --
09/30/2017 Q3 -- $4.9B $0.32 -- --
06/30/2017 Q2 -- $4.6B $0.33 -- --
03/31/2017 Q1 -- $4.3B $0.27 -- --
12/31/2016 Q4 -- $4.3B $0.31 -- --
09/30/2016 Q3 -- $4.2B $0.30 -- --
06/30/2016 Q2 -- $4.3B $0.32 -- --
03/31/2016 Q1 -- $4B $0.28 -- --
12/31/2015 Q4 -- $4.3B $0.28 -- --

Kühne + Nagel International AG Earnings Questions

  • How Much did Kühne + Nagel International AG Generate in Revenue Last Quarter?

    Kühne + Nagel International AG reported $7.6B worth of top line sales in its most recent quarter.

  • Did Kühne + Nagel International AG Beat Earnings Last Quarter?

    Kühne + Nagel International AG announced earnings per share of $0.42 which represents a beat of analyst forecast a -- per share.

  • Is Kühne + Nagel International AG Profitable?

    Kühne + Nagel International AG reported $808.5M that represents $1.39 per share over the last quarter.

  • What is the Analyst Consensus for Kühne + Nagel International AG EPS Next Year?

    Kühne + Nagel International AG's earnings are forecast to grow from $2.26 per share to -- per share next year representing an increase of --.

  • When is Kühne + Nagel International AG's Earnings Date?

    Kühne + Nagel International AG's next earnings date is March 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock